Results 41 to 50 of about 6,234 (145)

Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results

open access: yes, 2004
Background: Breast cancer is the most frequent solid tumor in women. The incidence is increasing. In Germany, about 45,000 women are newly diagnosed each year. The general strategy aims for the best local control of the tumor by surgery and radiotherapy.
Haase, Detlef, Hanf, Volker, Schulz, T.
core   +1 more source

Cytotoxic drugs in drinking water: a prediction and risk assessment exercise for the Thames catchment in the United Kingdom

open access: yes, 2009
Cytotoxic, also known as antineoplastic, drugs remain an important weapon in the fight against cancer. This study considers the water quality implications for the Thames catchment (UK) arising from the routine discharge of these drugs after use, down ...
Williams, Richard J.   +2 more
core   +1 more source

Metabolic Activation And Antineoplastic-Selective Mechanism Of Action Of Two Novel Fluoropyrimidines (hplc, High Pressure Liquid Chromatography, Tetrahydrouridine, Fluorouracil)

open access: yes, 1986
The coadministration of tetrahydrouridine (H(,4)Urd) diverted the metabolism of ('3)H-5-fluoro-2'-deoxycytidine (FdCyd) in human epidermoid laryngeal carcinoma (HEp-2) cells through the deoxycytidine kinase-deoxycytidylate deaminase (dCK-dCMPD) pathway ...
Boothman, David
core   +1 more source

RESPONSE OF SACCHAROMYCES-CEREVISIAE STRAINS TO ANTINEOPLASTIC AGENTS

open access: yes, 1995
The effect of several antineoplastic agents on Saccharomyces cerevisiae strains has been investigated. Minimum inhibitory concentration (MIC), minimum cytotoxic concentration (MCC) and median effective concentration (EC(50)) were determined to identify ...
DELITHEOS, A   +2 more
core  

Protective Effect of Silver Nanoparticles Against Cytosine Arabinoside Genotoxicity: An In Vivo Micronucleus Assay

open access: yes
Cancer treatments have harmful side effects, including genotoxic ones. Our previous research discovered that a specific silver nanoparticle (AgNPs) formulation could reduce the genotoxic effects of an alkylating agent, cyclophosphamide.
Alexey Pestryakov   +7 more
core   +1 more source

Determination of the mechanism of action of anticancer drugs by means of the computer-assisted microscope image analysis of Feulgen-stained nuclei.

open access: yes, 1997
The antitumoral effects of 30 drugs was monitored in vitro on three neoplastic cell lines. These 30 drugs belonged to various pharmacological classes which included alkylating agents, antimetabolites, Vinca alkaloids, topoisomerase II inhibitors, and ...
Atassi, Ghanem   +7 more
core   +1 more source

Intraoperative radiation therapy in integrated treatment of rectal cancers. Results of phase II study

open access: yes, 1996
Risk of local recurrence of rectal cancer remains high despite extensive therapeutic strategies, many of which have been tried to achieve better local control (i.e., external beam radiation therapy (EBRT)).
Bellantone, Rocco Domenico Alfonso   +6 more
core  

Radiation Recall with Anticancer Agents

open access: yes, 2010
Radiation recall is an acute inflammatory reaction confined to previously irradiated areas that can be triggered when chemotherapy agents are administered after radiotherapy.
Jane Hurtig, Howard A. Burris
core   +1 more source

Precision cardio-oncology: understanding the cardiotoxicity of cancer therapy

open access: yes, 2017
Current oncologic treatments have brought a strong reduction in mortality in cancer patients. However, the cancer therapy-related cardiovascular complications, in particular chemo-therapy and radiation therapy-induced cardiotoxicities are a major cause ...
Xinqiang Han   +5 more
core   +1 more source

Analogs of alkyllysophospholipids: chemistry, effects on the molecular level and their consequences for normal and malignant cells

open access: yes, 1995
In the search for new approaches to cancer therapy, the first alkyllysophospholipid (ALP) analogs were designed and studied about two decades ago, either as potential immunomodulators or as antimetabolites of phospholipid metabolism.
Vollgraf, C., Brachwitz, H.
core   +1 more source

Home - About - Disclaimer - Privacy